Introduction
Chronic organ dysfunction is the most common cause of morbidity among aging individuals. Generally, the process of organ dysfunction begins slowly, but it is progressive and intractable in its chronic phase. From a mechanistic viewpoint, chronic organ dysfunction can be explained as a disruption of physiological homeostasis and the processes responsible for organ maintenance and repair. This is particularly true for the vascular system, which plays central roles in the maintenance of organ homeostasis 1, 2 . Revealing the mechanisms underlying the functional integrity of the vascular system could make available novel therapeutic approaches to the treatment of organ dysfunction.
Vascular endothelial cells (ECs) and vasoactive molecules play key roles in the maintenance of vascular homeostasis . ECs actively secrete a variety of bioactive molecules, including nitric oxide, atrial natriuretic peptide (ANP), prostacyclin and adrenomedullin (AM). Originally identified as a vasodilating peptide isolated from human pheochromocytoma 5 , AM is now known to be widely secreted from a variety of organs and tissues, including ECs, and to be involved in a number of biological functions . Plasma levels of AM are elevated in patients with such cardiovascular diseases as hypertension and congestive heart failure . Moreover, it was recently reported that plasma AM levels are a highly sensitive marker of chronic kidney disease (CKD) that may be predictive of its prognosis 16 . We previously showed that homozygotic AM knockout (KO) (AM-/-) mice die at mid-gestation due to edema and hemorrhage, and clarified the critical role of AM in angiogenesis 17 . Heterozygotic AM KO (AM+/-) mice grow to adulthood with no apparent deficits, but show accelerated cardiac hypertrophy, fibrosis, renal failure, and arteriosclerosis upon cardiovascular injury. Given these observations, the clinical application of AM has been much anticipated [18] [19] [20] [21] [22] ; however, AM is a peptide with a short half-life in the bloodstream, which limits its usefulness for the treatment of chronic diseases.
To overcome that limitation, we have been focusing on AM's receptor system. AM is a member of the calcitonin superfamily and acts via a G protein-coupled seven transmembrane domain receptor, calcitonin-receptor-like receptor (CLR) 23, 24 . The specificity of CLR for its ligands is regulated by a group of three receptor-activity-modifying proteins, RAMP1, -2 and -3. We have shown that homozygotic RAMP2 KO (RAMP2-/-) mice die in utero.
Interestingly, among the RAMP KO mice, RAMP2-/-mice die from vascular abnormalities similar to those observed in AM-/-mice 25 . This suggests RAMP2 is the key determinant of AM's vascular function.
Our aim in the present study was to clarify the pathophysiological function of the vascular AM-RAMP2 system directly. To accomplish that, we generated and utilized four KO models: EC-specific (E)-RAMP2-/-, aged conventional RAMP2+/-, drug-inducible (DI)-E-RAMP2-/-and EC-specific (E)-AM-/-mice. With these models, we were able to determine both the acute and chronic effects of RAMP2 deletion, and demonstrate the contribution made by the AM-RAMP2 system to the maintenance of vascular integrity and organ homeostasis.
Methods

Mouse models
Vascular endothelial cadherin (VE-cadherin) Cre transgenic mice and mice expressing tamoxifen-inducible Cre-recombinase (Cre-ERT2) under the regulation of VE-cadherin promoter were crossed with floxed RAMP2 mice (RAMP2flox/flox) to create vascular EC-specific RAMP2 conditional KO mice (E-RAMP2-/-) ( Fig. 1a) and tamoxifen drug-inducible (DI) vascular EC-specific RAMP2 KO mice (DI-E-RAMP2-/-) ( Fig. 6a) , respectively.
Quantitative real-time RT-PCR analysis
The primers and probes used are listed in Supplemental Table. 3.
For other experimental procedures, please refer to Supplemental File.
Results
Generation of vascular EC-specific RAMP2 KO mice
Conventional RAMP2-/-embryos died at mid-gestation (around 14.5 dpc), as we reported previously 25 . By contrast, EC-specific RAMP2-/-(E-RAMP2-/-) embryos survived until later in development, though most died during the perinatal period (Fig. 1b) . Among the RAMP2 flox/flox Cre+/-intercrosses, the estimated survival rate of E-RAMP2-/-mice at 4
weeks of age was less than 5% (Supplemental Table 1 ). Perinatal stage E-RAMP2-/-mice exhibited systemic edema (Fig. 1c, d ), as well as interstitial edema within the intestinal villi ( Fig. 1e) and lung ( Fig. 1f) , and severe hemorrhagic changes within the liver (Fig. 1g) . As expected, E-RAMP2-/-mice showed vascular abnormalities, including malformation of aortic ECs (Fig.1h ) and partial detachment of ECs from the basement membrane (Fig.1i, j) .
Abnormalities in the vascular structure of surviving E-RAMP2-/-adults
In the 5% of E-RAMP2-/-mice that survived until adulthood, RAMP2 expression in aortic ECs was 20% of that in their littermate controls (Cont) (data not shown). The surviving E-RAMP2-/-adults also exhibited thinning of the aortic wall and enlarged aortic diameters (Fig. 1k, l) . Both systolic and diastolic blood pressures (SBP and DBP) were lower in E-RAMP2-/-than Cont mice (Fig. 1m) . Electron microscopic observation revealed that the aortic smooth muscle layer was in disarray in E-RAMP2-/-mice (Fig. 1o) , and that the ECs were detached from the basement membrane and severely deformed (Fig. 1n ). These morphological changes in the vascular cells may partially explain the enlargement of the aorta and reduction in blood pressure. Given these observations, we speculated that EC viability was diminished in E-RAMP2-/-mice, which was confirmed by the severe disruption of angiogenesis seen in ex vivo aortic ring assays (Fig. 1p ).
Severe vascular inflammation and organ fibrosis in E-RAMP2-/-adults
Vasculitic lesions developed spontaneously in surviving E-RAMP2-/-adults, beginning
when they were about 6-month-old, and severe infiltration and accumulation of inflammatory cells was observed in blood vessels within the major organs, including the liver (Fig. 2a) , kidneys ( Fig. 2b ) and lungs (Fig. 2c) . The infiltrating cells were CD3+ or F4/80+, which is indicative of T cells and macrophages, respectively (Fig. 2d, e ). In addition, the expression of inflammatory cytokines and macrophage markers was also upregulated (Fig. 2f) .
We speculated that the vascular damage in the surviving adult E-RAMP2-/-mice was the primary cause of the vasculitis. In that regard, it was recently suggested that vascular damage may be the cause of vascular senescence 26, 27 . To test whether these phenomena indicate accelerated senescence, we next evaluated aged conventional RAMP2 KO mice (RAMP2+/-). At 2 years of age, RAMP2+/-mice showed inflammatory cell infiltration of the main organs ( Fig. 2g-i ). Senescence-associated (SA)-β-gal staining, which is commonly used to assess accelerated aging, was more intense in the aortas of the aged RAMP2+/-than WT mice (Fig. 2j) . Moreover, the SA-β-gal staining could be detected at a much younger age (6 months) in E-RAMP2-/-mice (Fig. 2k) .
The presence of activated Akt and p53 in the aorta is another recognized marker of vascular senescence 28 . Levels of Akt and p53 activation were much greater in aged RAMP2+/-than WT mice (Fig. 2l) . No difference was seen between the levels of Akt and p53 activation in younger RAMP2+/-and WT mice, though the inflammatory cell adhesion markers ICAM-1 and VCAM-1 were already upregulated in the young RAMP2+/-animals. This is consistent with the idea that vascular senescence is preceded by vascular damage and inflammation.
More interestingly, organ damage developed spontaneously in E-RAMP2-/-adults. In particular, the livers of E-RAMP2-/-mice appeared cirrhotic by the time the animals were 6 months old (Fig. 3a) . Pathological analysis revealed that the cirrhosis-like changes were not caused by damage to parenchymal hepatocytes, but by severe fibrosis along the vasculature within the liver, most likely due to dysfunction of the sinusoidal ECs (Fig. 3b, c ). Cardiac enlargement with interstitial fibrosis was also seen in 6-month-old E-RAMP2-/-mice ( Fig. 3d,   e ). In addition, quantitative real-time PCR showed elevated expression of ANP, brain natriuretic peptide (BNP) and transforming growth factor-β (TGF-β), which is indicative of heart failure and fibrosis (Fig. 3f ). In addition, spontaneous hydronephrosis ( Fig. 3g ) and polycystic changes (Fig. 3h) were noted in the kidneys of E-RAMP2-/-mice, as was glomerular enlargement and sclerotic changes (Fig. 3i) . Electron microscopy revealed podocyte fusion, hyperplasia of the basal membrane, and partial dehiscence between the glomerular ECs and basal membrane (Fig. 3j) . Renal expression of TGF-β and collagen was also upregulated in E-RAMP2-/-mice (Fig. 3k) .
EC-specific AM KO mice showed vascular inflammation and glomerulosclerosis
We next compared EC-specific AM KO (E-AM-/-) with E-RAMP2-/-. In contrast to E-RAMP2-/-neonates, E-AM-/-neonates were healthy and presented no overtly pathophysiological phenotypes (Supplemental Table 2 ). We suggest that in E-AM-/-neonates, circulating and/or paracrine AM from sources other than ECs likely attenuate the phenotypes observed in E-RAMP2-/-neonates. In adults, however, the vascular inflammation and organ damage were similar to those seen in E-RAMP2-/-mice. E-AM-/-mice showed severe infiltration and accumulation of inflammatory cells around the vasculature (Fig. 4a, b) . They also showed glomerulosclerotic changes with mesangial expansion and upregulation of inflammatory molecules ( Fig. 4c-e ).
RAMP2 deficiency enhances inflammatory reactions in both ECs and leukocytes
We speculated that the observed vasculitic lesions began with the cellular adhesion of inflammatory cells to ECs. To test that idea, we initially examined the effect of endothelial RAMP2-deficiency on the interaction between ECs and macrophages in vitro. After isolating and culturing LSECs from RAMP2+/-and WT mice, we evaluated the attachment of macrophages isolated from GFP-mice (provided by Prof. Sato of Kagoshima University).
We found that GFP+ macrophages attached more readily to RAMP2+/-LSECs than to WT LSECs ( Fig. 5a , b), and that VCAM-1 expression was higher in RAMP2+/-LSECs than in WT cells (Fig. 5c ).
To then assess the effect of RAMP2-deficiency on the leukocytes, we crossbred DsRed+ (provided by Dr. Tagawa of the Tokyo Institute of Technology) with RAMP2+/-mice to generate a DsRed+RAMP2+/-mouse line. We found that both peripheral leukocytes ( Fig. 5d , e) and peritoneal macrophages ( Fig. 5f, g ) collected from DsRed+RAMP2+/-attached more readily to LSECs than did WT. Phagocytosis of macrophages was not different between WT and RAMP2+/- (Fig. 5h, i) , however, expression of the inflammation markers, including monocyte chemotactic protein-1 (MCP-1), interleukin-6 (IL-6), and IL-1β
were upregulated in RAMP2+/-macrophages ( Fig. 5j ). This suggests that attached more readily to LSECs than did WT. Phagocytosis of macrophages was not different between WT and RAMP2+/- (Fig. 5h, i) , however, expression of the inflammation markers, including monocyte chemotactic protein-1 (MCP-1), interleukin-6 (IL-6), and IL-1β
were upregulated in RAMP2+/-macrophages (Fig. 5j ). This suggests that RAMP2-deficiency in leukocytes, as well as in ECs, enhances inflammatory reactions, and that both likely contribute to the chronic inflammation observed in aged RAMP2+/-mice.
RAMP2 deficiency increases oxidative stress, while RAMP2 overexpression leads to resistance to senescence under conditions of oxidative stress in ECs
It has been reported that AM exerts antioxidant effects. In 6-month-old E-RAMP2-/-mice, we detected elevated levels of oxidative stress in the major organs. Levels of 4-hydroxy-2-nonenal (4HNE) immunostaining, which reveals the presence of peroxides of unsaturated fatty acids, were increased in E-RAMP2-/- (Fig. 5k ). Consistent with this finding, expression of three NADPH-oxidase subunits (p22-phox, p47-phox and p67-phox) were elevated ( Fig. 5l) . Thus RAMP2-deficiency in ECs appears to exacerbate oxidative stress.
We next used EAhy926 ECs to generate EC lines stably overexpressing RAMP2.
H 2 O 2 -treatment has been shown to induce EC senescence 29 . We found that after incubation for 24 h in the presence of H 2 O 2 plus AM, control cells were strongly stained by SA-β-gal, but cells overexpressing RAMP2 were resistant to staining (Fig. 5m ).
Initial EC change elicited by RAMP2 deletion in drug-inducible EC-specific RAMP2
KO mice
As mentioned, most E-RAMP2-/-mice died as neonates and analysis using adult mice d). The cause of the edema was enhanced vascular permeability and plasma leakage, as evidenced by the extravascular leakage of Evans Blue dye (Fig. 6e) . In a hind-limb ischemia model, which enables us to evaluate the post-natal angiogenic potency, we also found that blood flow recovery was delayed in DI-E-RAMP2-/- (Fig. 6f) .
Next, we evaluated whether we could rescue the phenotype of DI-E-RAMP2-/-by vascular overexpression of RAMP2 gene. We employed the gene delivery method in the hind-limb ischemia model by electroporation of plasmid, which could overexpress RAMP2
under the control of VE-cadherin promoter (Supplemental Fig. 1 ). At first, we confirmed the VE-cadherin promoter works only in vascular endothelial cells; when VE-cadherin-EGFP plasmid is electroporated at the femoral region, the signal was detected only at the isolectin-positive endothelial cells (Fig. 6g) . In addition, after 24 h of electroporation of VE-cadherin-RAMP2 plasmid, we confirmed that RAMP2 expression was strongly induced in DI-E-RAMP2-/- (Fig. 6h) . Actually, the RAMP2 gene delivery in DI-E-RAMP2-/-successfully restored the blood flow recovery in the hind-limb ischemia (Fig. 6i, j) . Moreover, the RAMP2 gene delivery enhanced capillary formation and reduced interstitial edema in DI-E-RAMP2-/- (Fig. 6k, l) .
Using the DI-E-RAMP2-/-line, we further evaluated the primary cause of the vascular failure. In electron micrographs of aortas obtained 2 weeks after RAMP2-deletion, ECs in DI-E-RAMP2-/-mice appeared deformed and were detached from the basement membrane (Fig. 6m) . We speculated that the cause was cytoskeletal abnormality within the ECs.
Consistent with that idea, actin polymerization in DI-E-RAMP2-/-ECs appeared in disarray,
and there was a loss of actin-bundle formation under the plasma membrane (cortical actin formation) (Fig. 6n) . It has been reported that small GTPases, Rac1 and RhoA, play crucial roles in the regulation of ECs' barrier function by regulating the formation cortical actin and stress fibers 30 . When we analyzed the activation of Rac1 and RhoA in DI-E-RAMP2-/-ECs, we found that levels of the activated form of Rac1 (Rac1-GTP) were significantly reduced, whereas the activated form of RhoA (RhoA-GTP) was increased (Fig. 6o, p) . On the other hand, AM-treatment enhanced cortical actin formation in HUVECs (Fig. 6q) . Notably, the Rac1 inhibitor NSC23766 blocked the AM-induced enhancement of cortical action formation, whereas Rho-associated protein kinase (ROCK) inhibitor Y27632 had no effect (Fig. 6r ).
Taken together, these observations suggest the AM-RAMP2 system regulates the Rac1-GTP/RhoA-GTP ratio and therefore cortical actin formation, and that a defect in this system will disrupt actin formation.
We also confirmed that at the chronic stage after the gene-deletion, DI-E-RAMP2-/-mice exhibited vascular damage with enhanced perivascular inflammation that was the same as that of adult E-RAMP2-/- (Fig. 7) . With DI-E-RAMP2-/-, therefore, we were able to clarify both the acute and chronic effects of RAMP2 deletion in the adult, and demonstrate that RAMP2 is essential for EC viability, vascular integrity, and homeostasis.
Discussion
Our initial finding was that most E-RAMP2-/-mice die perinatally from severe systemic edema. In contrast to conventional RAMP2-/-embryos, which die at mid-gestation, E-RAMP2-/-embryos survived until later stages of development. As we and other groups reported previously, in conventional RAMP2-/-embryos, deformity was detected in both the endothelium and the smooth muscle layer in both blood and lymphatic vessels 25, 31 . By contrast, in the E-RAMP2-/-embryos used in this study, the lesion was limited in the ECs, which likely accounts for their longer survival. Nonetheless, most E-RAMP2-/-died due to edema, reflecting the endothelial abnormality and vascular leakage. Clearly, endogenous RAMP2 is essential for EC viability and vascular integrity.
About 5% of E-RAMP2-/-mice survived to adulthood. E-RAMP2-/-adults were apparently normal when young, but showed EC deformity and reduced viability later.
Interestingly, the cellular deformities in the adult animals was not limited to the endothelium, but also included the smooth muscle cell layer, which suggests the congenital EC abnormalities induced secondary postnatal disorder of other vascular component cells.
E-RAMP2-/-mice also had lower blood pressures than WT mice, which seems contradictory, as AM is well known to be a vasodilator. We speculate that the reduction in blood pressure might be due to the observed morphological changes in the vascular cells. Another possibility is that our findings are consistent with the report that although AM is a vasodilator when injected peripherally, it is a vasoconstrictor when injected intracerebrally 32 ; that is, when endothelial RAMP2 deficiency affects both peripheral and central AM signaling, the expected central phenotype is observed.
E-RAMP2-/-adults also showed marked accumulation of inflammatory cells along the blood vessels within major organs, and the chronic vascular damage by such inflammation can accelerate vascular senescence 28, [33] [34] [35] . We found that activation of aortic Akt and p53, as well as SA-β-gal staining, two indicators of vascular senescence, were enhanced in adult E-RAMP2-/-mice, and that similar vasculitic lesions were present in aged conventional RAMP2+/-mice. The vascular lesions in E-RAMP2-/-mice led to organ damage, which included liver cirrhosis, cardiac enlargement with fibrosis, hydronephrosis, polycystic changes in the kidney and glomerulosclerosis. Taken together, these findings suggest that endothelial RAMP2 deficiency is the primary cause of subsequent vascular inflammation, accelerated senescence, fibrosis, and chronic organ dysfunction.
Unlike virus-related liver cirrhosis, in which the lesion starts within the hepatocytes, the cirrhotic changes seen in E-RAMP2-/-mice were caused by severe fibrosis that started in the vasculature. This is consistent with idea that vascular damage is the primary cause of this cirrhosis. In the E-RAMP2-/-kidney, both glomerular and interstitial changes were observed, along with epithelial cell damage (podocyte fusion) associated with glomerular EC deformity.
And in the heart, cardiac enlargement and fibrosis led to heart failure. Thus loss of EC viability and vascular integrity accelerated vascular senescence and exacerbated interstitial lesions, making it the primary cause of chronic organ dysfunction.
For this study, we also generated EC-specific AM KO mice (E-AM-/-). In contrast to E-RAMP2-/-neonates, the E-AM-/-neonates appeared healthy. It seems the phenotype caused by knocking out the ligand during development is much milder than the one caused by knocking out the receptor. This is likely because AM is secreted from cells other than ECs, and circulating and/or paracrine AM from these other sources compensate for the endothelial AM deficiency during development. In adults, however, the chronic reduction in AM signaling led to vascular inflammation and chronic organ damage in E-AM-/-mice, suggesting that aging is another important factor contributing to the emergence of the pathophysiological phenotype.
To better understand the mechanism by which endothelial RAMP2 deficiency could promote the aforementioned pathological features, we first characterized the inflammatory response triggered in RAMP2-deficient ECs. We recently reported that the expression of We also found high levels of oxidative stress, including elevation of NADPH-oxidase levels, within the major organs of E-RAMP2-/-mice. It has been reported that AM exerts strong antioxidant effects , and in the present study AM protected ECs stably overexpressing RAMP2 from cellular senescence induced by oxidative stress. This suggests that AM-RAMP2 signaling suppresses oxidative stress, and that endothelial RAMP2 may be an effective target through which to regulate oxidative stress.
Because most E-RAMP2-/-mice die as neonates, analysis of adult animals has been limited. To overcome this limitation, we generated a drug-inducible EC-specific RAMP2 KO
mouse (DI-E-RAMP2-/-). In this model, we can induce RAMP2 gene deletion in adults on
demand and then analyze the changes induced by RAMP2 deletion. Interestingly, DI-E-RAMP2-/-mice exhibit marked systemic edema caused by increased vascular permeability. It is widely recognized that an increase in intracellular cyclic adenosine monophosphate (cAMP) within ECs strengthens their barrier function and reduces endothelial permeability, both in vitro and in vivo 30, 37 . It is therefore not surprising that cAMP-elevating G protein-coupled receptor agonists, such as AM, prostacyclin and prostaglandin E2, reduce endothelial hyperpermeability induced by inflammatory stimuli 38 .
In addition, small GTPases, especially Rac1 and RhoA, play crucial roles in the regulation of EC barrier function by regulating the formation of cortical actin and stress fibers, respectively 30 Elevation of cAMP leads to Rac1 activation, which in turn strengthens endothelial barrier function by enhancing cortical actin ring formation 39 . We found that in DI-E-RAMP2-/-ECs, actin polymerization was disrupted and Rac1 activation was reduced.
By contrast, AM-stimulated ECs showed cortical actin formation, which disappeared upon treatment with a Rac1 inhibitor. Taken together, these findings suggest that in DI-E-RAMP2-/-ECs, downregulation of cAMP production and Rac1 activation reduces cortical actin formation, diminishing endothelial barrier function.
The relationship between the AM receptor and human disease has also been reported. A human SNP study described the relationship between CLR with essential hypertension . A human study also revealed the relationship between RAMP1 SNPs with the incidence of cerebral infarction . Some human mutations of RAMP3 gene have also been reported . On the other hand, there have been no reports on human RAMP2 gene mutation. As we have shown, RAMP2-deletion can cause embryonic lethality at mid-gestation, and this may be one reason that we cannot see human congenital disease. In this context, the endothelial cell-specific conditional knockout mice model in this study should be recognized as a model of vascular failure and relevant organ dysfunction and should not be recognized as a specific congenital disease model.
In this study, we were able to clarify both the acute and chronic effects of RAMP2 deletion in the adult, and to demonstrate that the AM-RAMP2 system is essential for vascular integrity and organ homeostasis. The illustration in Figure 8 Finally, the accumulated disorders cause chronic organ dysfunction with aging. The results
obtained using these models demonstrate that vascular EC integrity is essential for organ homeostasis. We also suggest that RAMP2, via which we could modulate vascular integrity, is a potentially useful therapeutic target for the treatment of chronic organ dysfunction. (n, o) Electron micrographs of adult aortas. E-RAMP2-/-aortas showed detachment of ECs (n) and a disordered smooth muscle layer (o). Scale bars = 5 µm.
(p) ex vivo analysis of angiogenesis using adult aortic ring specimens after 14 days of culture in collagen gel. 
(g-i)
Vasculitic lesions similar to those in E-RAMP2-/-were confirmed in aged (2-year-old) conventional RAMP2+/-(Scale bars = 100µm).
(j, k) SA-β-gal staining of aorta. In aged mice (2 year-old), aortic SA-β-gal staining was more intense in RAMP2+/-than wild-type mice (WT) (j). The SA-β-gal positivity was detected much earlier (6 months of age) in E-RAMP2-/-than Cont (k). Scale bars = 100 µm. (n) LSECs cultured from control and DI-E-RAMP2-/-mice were stained with rhodamine-phalloidin to visualize F-actin. Scale bars = 50 µm.
(o) Western blots of Rac1-GTP, total Rac1, Rho-GTP and total Rho from ECs. 
